BlackRock Fund Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$144M	Buy	1,895,542 +63,731	+3%	+$4.84M	0.03%	902
2016 Q3	$153M	Buy	1,831,811 +77,014	+4%	+$6.46M	0.03%	735
2016 Q2	$145M	Buy	1,754,797 +85,280	+5%	+$7.02M	0.03%	702
2016 Q1	$127M	Sell	1,669,517 -14,644	-0.9%	-$1.08M	0.03%	765
2015 Q4	$135M	Buy	1,684,161 +69,142	+4%	+$4.99M	0.03%	733
2015 Q3	$103M	Buy	1,615,019 +1,234	+0.1%	+$88.6K	0.03%	883
2015 Q2	$114M	Buy	1,613,785 +90,319	+6%	+$6.68M	0.03%	889
2015 Q1	$121M	Buy	1,523,466 +156,222	+11%	+$11.5M	0.03%	834
2014 Q4	$87M	Sell	1,367,244 -24,730	-2%	-$1.55M	0.02%	1054
2014 Q3	$83.2M	Buy	1,391,974 +17,058	+1%	+$976K	0.02%	991
2014 Q2	$73.6M	Buy	1,374,916 +62,346	+5%	+$3.42M	0.02%	1129
2014 Q1	$79.2M	Sell	1,312,570 -69,507	-5%	-$4.05M	0.02%	1041
2013 Q4	$73.3M	Buy	1,382,077 +103,569	+8%	+$5.2M	0.02%	1094
2013 Q3	$59.1M	Buy	1,278,508 +59,395	+5%	+$2.73M	0.02%	1193
2013 Q2	$50M	Buy	+1,219,113	New	+$52.2M	0.02%	1204